It is hypothesized that promoting antioxidants and Phase II detoxifying enzymes via activating Nrf2 nuclear translocation might be responsible for CF and AF protecting SH-SY5Y cells from TBHP-induced oxidative damage. The gene discussed is NFE2L2; the disease is atrial fibrillation.